DIAH

DIAH 2026

19 – 21 May 2026 | Bruges, Belgium

Wednesday, 20 May 2026 | 14:00 - 14:45

Masterclass 2: Illuminating Mechanism of Action in Veterinary Antibody R&D: From Biology to Functional Bioassays

Location:BMCC - 3rd Floor - Cat RoomTrack:Masterclass

Sign-ups available from 1 Apr 2026, 00:00 to 20 May 2026, 14:45

Illuminating Mechanism of Action in Veterinary Antibody R&D: From Biology to Functional Bioassays

This Masterclass will present a joint Promega– Boehringer Ingelheim session focused on illuminating mechanism-of-action (MoA) strategies in veterinary antibody research and development through the application of luminescent bioassays. The session will demonstrate how MoA-driven assay design can support veterinary antibody programs from discovery through early development, bridging biological understanding with translational decision-making.

Participants will learn how luminescent reporter, binding, and functional bioassays can be leveraged to generate sensitive, robust, and biologically relevant data that inform target validation, functional potency, and early development decisions. The session will integrate scientific perspective with practical, real-world experience drawn from industry case studies.

In addition, the Masterclass will highlight Promega Tailored Research Services (TRS) as a collaborative partner in co-developing and optimizing MoA-relevant bioassays tailored to program-specific needs. This session is designed for animal health R&D scientists seeking innovative, scalable bioanalytical approaches to strengthen MoA confidence and accelerate veterinary antibody development.

_
Jennifer Serriere-Di Bartolo (Promega) & Jens Radzimanowski (Boehringer Ingelheim)_

2 speakers